Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Meeting/Conference Proceedings

Deprescribing Guidelines: Special Section on Symposium Results.

Res Social Adm Pharm. 2019;15(6):780-810.

Save
Print
June 26, 2019

Res Social Adm Pharm. 2019;15(6):780-810.

View more articles from the same authors.

Appropriate deprescribing can reduce the risks associated with polypharmacy, overuse, and accidental overdose. Articles in this special section cover findings from a symposium discussing guidelines for safe discontinuation of medications and research needed to support further understanding of deprescribing practices.

Save
Print
Cite
Citation

Res Social Adm Pharm. 2019;15(6):780-810.

Related Resources From the Same Author(s)
Related Resources